Skip to main content

Want a detailed portfolio tracker?

MapLight Therapeutics (MPLT) P/E (2025 - 2026)

MapLight Therapeutics (MPLT) P/E from Dec 31, 2025 to Jul 21, 2026. The TTM MapLight Therapeutics (MPLT) P/E is -11.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MapLight Therapeutics (MPLT)

YearP/EChange
2026-11.89+22.31%
2025-9.72N/A

Comparison MapLight Therapeutics (MPLT) P/E with competitors

MapLight Therapeutics (MPLT) P/E is -11.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.63%
FGENFibroGen Inc0.24-102.02%
CHRSCoherus Biosciences Inc0.85-107.14%
FBIOFortress Biotech Inc0.95-107.98%
ORMPOramed Pharmaceuticals Inc1.50-112.64%
AGENAgenus Inc3.01-125.31%
INVAInnoviva Inc3.15-126.53%
VXRTVaxart Inc3.55-129.85%
CRMDCorMedix Inc3.63-130.52%
CVACCureVac N.V.4.45-137.39%
GLPGGalapagos NV4.86-140.86%
SRPTSarepta Therapeutics Inc4.88-141.06%
ABEOAbeona Therapeutics Inc5.39-145.31%
ABUSArbutus Biopharma Corp5.60-147.06%
ZVRAZevra Therapeutics Inc5.89-149.51%
SPROSpero Therapeutics Inc6.23-152.38%
CGENCompugen Ltd6.31-153.10%
RIGLRigel Pharmaceuticals6.87-157.80%
SLXNSilexion Therapeutics Corp7.30-161.36%
OMEROmeros Corporation9.26-177.87%
AUPHAurinia Pharmaceuticals Inc9.58-180.61%
PLXProtalix BioTherapeutics Inc10.89-191.60%
ACADAcadia Pharmaceuticals Inc11.73-198.64%
TBPHTheravance Biopharma Inc12.26-203.13%
ADMAAdma Biologics Inc12.42-204.44%
HRMYHarmony Biosciences Holdings Inc13.82-216.23%
SABSSAB Biotherapeutics Inc14.14-218.89%
NAGENiagen Bioscience Inc14.82-224.63%
INCYIncyte Corp15.82-233.07%
REGNRegeneron Pharmaceuticals Inc15.86-233.36%
PBYIPuma Biotechnology Inc17.32-245.63%
CPRXCatalyst Pharmaceuticals Inc17.44-246.67%
EXELExelixis Inc17.54-247.50%
TGTXTG Therapeutics Inc18.97-259.51%
MDXGMimedx Group Inc20.55-272.85%
XOMAXOMA Royalty Corp22.87-292.39%
ARGXArgen X SE24.30-304.36%
CTMXCytomX Therapeutics Inc24.82-308.76%
XOMAOXOMA Royalty Corp25.34-313.17%
HALOHalozyme Therapeutics Inc25.62-315.51%
XOMAPXOMA Royalty Corp25.67-315.90%
VRTXVertex Pharmaceuticals Inc27.99-335.45%
RPRXRoyalty Pharma plc - Class A28.69-341.28%
SLNOSoleno Therapeutics Inc29.02-344.04%
ASNDAscendis Pharma A/S30.09-353.04%
LGNDLigand Pharmaceuticals Inc - Class B37.91-418.86%
APLSApellis Pharmaceuticals Inc39.02-428.19%
BMRNBiomarin Pharmaceutical Inc42.21-455.03%
KRYSKrystal Biotech Inc45.34-481.37%
ONCBeiGene Ltd69.54-684.88%
PHARPharming Group N.V.75.03-731.01%
TECHBio-Techne Corp101.96-957.53%
VCELVericel Corp109.92-1024.51%
ALNYAlnylam Pharmaceuticals Inc117.96-1092.16%
GMABGenmab140.29-1279.93%
TLXTelix Pharmaceuticals Ltd162.15-1463.80%
CORTCorcept Therapeutics Inc212.86-1890.26%